Nursing Assessment Is Critical to Optimize Outcomes With Immune Effector Cell–Associated HLH-Like Syndrome
Eliana Baker; Addi Georgantzis, MSN, RN, AGPCNP-BC, OCN®, BMTCN®
Voice
Description
Mrs. Brown (she/her) is a 70-year-old assigned female at birth with a history of diffuse large B-cell lymphoma (DLBCL) with central nervous system involvement. She received axicabtagene ciloleucel and tolerated the immune effector cell (IEC) infusion.